NEN 70 4 2011 03 04 COOPER 200739 SDC5
1
Supplementary Figure 5. Changes in sarcoglycan expression do not correlate with genetic cause or disease severity in known forms of muscular dystrophy. Western blot analysis of - and -sarcoglycan expression in 2 Duchenne muscular dystrophy (DMD) patients (lanes 2, 3), 2 dysferlinopathy patients (Dysf; lanes 5, 6) and 2 caveolinopathy patients (Cav; lanes 8, 9) demonstrates variable levels of the sarcoglycans without a clear relationship with diagnosis or disease severity. Lanes 1, 4, 7 & 10 are age-matched controls (C). Right panel shows standard curves for each protein (Std Curve).
description
- PowerPoint PPT Presentation
Transcript of NEN 70 4 2011 03 04 COOPER 200739 SDC5
Supplementary Figure 5. Changes in sarcoglycan expression do not correlate with genetic cause or disease severity in known forms of muscular dystrophy. Western blot analysis of - and -sarcoglycan expression in 2 Duchenne muscular dystrophy (DMD) patients (lanes 2, 3), 2 dysferlinopathy patients (Dysf; lanes 5, 6) and 2 caveolinopathy patients (Cav; lanes 8, 9) demonstrates variable levels of the sarcoglycans without a clear relationship with diagnosis or disease severity. Lanes 1, 4, 7 & 10 are age-matched controls (C). Right panel shows standard curves for each protein (Std Curve).
